Please login to the form below
rheumatoid arthritis
This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.
Researchers use AI to identify drugs that could be repurposed for Alzheimer’s
JAK inhibitors are commonly used to treat conditions such as rheumatoid arthritis and blood cancers, and block the action of JAK proteins, which play a role in inflammation and are also
Latest news
-
Roche’s anti-inflammatory drug reduces deaths in hospitalised COVID-19 patients
Tocilizumab, which is commonly used to treat rheumatoid arthritis, was found to reduce the relative risk of death by 14% when used alongside the steroid dexamethasone in COVID-19 patients requiring
-
FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz
Xeljanz is approved in the US for use in adults with rheumatoid arthritis (RA) who have not responded well to methotrexate treatment. ... It is also approved to treat patients with psoriatic arthritis who have not responded well to prior methotrexate
-
Gilead’s Jyseleca is given a NICE recommendation for rheumatoid arthritis
JAK inhibitor approved for use in moderate-to-severe RA. Gilead Sciences’ rheumatoid arthritis (RA) treatment Jyseleca has been given a recommendation from the UK’s National Institute of Health and
-
Lilly’s repurposed COVID-19 med baricitinib bags FDA emergency approval
Drug approved for emergency use in combination with Gilead's remdesivir. Eli Lilly and Incyte’s arthritis treatment baricitinib has been repurposed as a COVID-19 treatment, scoring an emergency use ... 35%. Baricitinib is already marketed by Lilly as
-
Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses
Roche’s existing rheumatoid arthritis drug Actemra (tocilizumab) is also being studied in combination with Gilead’s antiviral remdesivir in hospitalised patients with severe COVID-19 pneumonia in the REMDACTA trial.
More from news
Approximately 57 fully matching, plus 444 partially matching documents found.
Latest Intelligence
-
The US celebrates five years of biosimilars on the market – a look to the past, present and future
chronic diseases such as rheumatoid arthritis.
-
NICE – but not enough
to severe rheumatoid arthritis.
-
AI: the smart money is on the smart thinking
Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
-
Cortellis Drugs to Watch in 2020 report
Sales are projected at $1.589bn in 2024. 5. Filgotinib from Gilead/Galapagos is an oral JAK1 inhibitor in regulatory review in the US, EU and Japan for rheumatoid arthritis Overactivation ... of the JAK family of kinases leads to an aberrant production
-
20 for 2020 – Five pharma leaders to watch in 2020
to 2025 built on the Prevnar franchise, rare disease therapy Vyndaqel (tafamidis), breast cancer therapy Ibrance (palbociclib) and arthritis drug Xeljanz (tofacitinib), among others. ... filgotinib for rheumatoid arthritis.
More from intelligence
Approximately 0 fully matching, plus 42 partially matching documents found.
Latest appointments
-
Portland Health appoints Jamie Hewitt as an account director
He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions. ... During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to
-
Liberation Unlimited promotes Vicky Smith
oncology, rheumatoid arthritis and eye health.
-
Galapagos appoints Bart Filius as chief financial officer
His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
-
TiGenix appoints Dr Marie Paule Richard
In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
-
Liberation promotes Danielle Smith to account director
Meanwhile, Vicky joined Liberation last year and in her new role will continue to work across a range of therapeutic areas including men's health, rheumatoid arthritis and eye health.
More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Covid-19: how is it affecting prescribing patterns?
In this article, we will examine three key disease areas: COPD, rheumatoid arthritis and multiple sclerosis to determine which drug types have been the winners and losers in terms of usage ... Rheumatoid arthritis. Rheumatoid arthritis has seen a
-
The other side of … rheumatoid arthritis
The other side of … rheumatoid arthritis. “I harassed my GP enough to get it caught early”. ... Meet Georgie. At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population
-
Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards
Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in rheumatoid ... arthritis (RA): Is there a missing link in RA management?
-
Lucid Group scoop a win and a high commendation at Communiqué 2020
Its programme – ‘LiBRA 2019: Looking beyond the joint in rheumatoid arthritis (RA): Is there a missing link in RA management?’ – won the category, with a high commendation going to ‘CLEAR HORIZONS – ... We were thrilled that our work in both
-
Lucid Group are shortlisted in three categories for Communiqué 2020
LiBRA 2019: Looking beyond the joint in rheumatoid arthritis (RA): Is there a missing link in RA management?
More from PMHub
Approximately 9 fully matching, plus 20 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
-
Account Management
-
Competitive Salary Offered
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Principal Medical Writer
-
Varies on experience
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- CureVac expands COVID-19 vaccine trial protocol to include variant specification
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- New study identifies drugs that are safe to use in COVID-19 treatment
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Opdivo improves survival in oesophageal cancer
- Keytruda shows significant and meaningfully improvement in kidney cancer
- Congress 2020 BC (before COVID-19)
- Shaping the Future of Medicine, Science, and Technology
- Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
PMHub
Langland
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...
Latest intelligence
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
- How to tell your healthcare story.
- Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....
Quick links
Infographics
